Feasibility and Pilot Testing of Group-based ACT for Adolescents With Functional Somatic Syndromes
AHEAD
Feasibility of Group-based Acceptance and Commitment Therapy for Adolescents (AHEAD) With Functional Somatic Syndromes: A Pilot Study
1 other identifier
interventional
21
0 countries
N/A
Brief Summary
Recurrent and impairing functional somatic syndromes (FSS) are common in adolescents. Despite a high need for care, empirically supported treatments are lacking for youth. The aim of the uncontrolled was to assess feasibility and treatment potential of group-based Acceptance and Commitment Therapy (ACT) in a generic treatment approach for adolescents with multiple FSS i.e. "ACT for Health in Adolescents" (AHEAD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2013
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 29, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 24, 2015
CompletedFirst Submitted
Initial submission to the registry
June 27, 2020
CompletedFirst Posted
Study publicly available on registry
July 9, 2020
CompletedJune 14, 2021
June 1, 2020
1.9 years
June 27, 2020
June 9, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Short Form Health Survey-36 (SF36) (Assessment of an aggregate score measuring physical health)
Questionnaire, patient rated. Physical health measured with aggregate scores of the scales PF (physical functioning), BP (bodily pain) and VT (vitality). Score range 15-65. Higher scores indicating a higher degree of self-rated physical health.
At baseline (i.e. at clinical assessment), and at 2, 4, 5, and 8 months (corresponding to group start, 8th, 9th module and follow up meeting)
Secondary Outcomes (10)
Change in Bodily Distress Syndrome checklist (BDS checklist)
At baseline (i.e. at clinical assessment), and at 2, 4, 5, and 8 months (corresponding to group start, 8th, 9th module and follow up meeting)
Change in Limitation index Questionnaire
At baseline (i.e. at clinical assessment), before psychiatric consultation (approximately 2 weeks after clinical assessment), and at 2, 3, 4, 5, and 8 months (corresponding to before therapy, after 4th, 8th, 9th module and at follow up meeting)
Change in Whiteley 7
At baseline (i.e. at clinical assessment), and at 2, 4, 5, and 8 months (corresponding to group start, 8th, 9th module and follow up meeting)
Change in SCL-8 Questionnaire
At baseline (i.e. at clinical assessment), and at 2, 4, 5, and 8 months (corresponding to group start, 8th, 9th module and follow up meeting)
Change in SF-36 PCS
At baseline (i.e. at clinical assessment), and at 2, 4, 5, and 8 months (corresponding to group start, 8th, 9th module and follow up meeting)
- +5 more secondary outcomes
Other Outcomes (2)
Modified version of ESQ Experience of Service Questionnaire
At 8 months corresponding to at follow up meeting
Questions concerning close relatives' satisfaction with information meeting
At meeting for close relatives corresponding to approximately 1 week after start of group therapy (i.e. at 2 months)
Study Arms (1)
Group-based Acceptance and Commitment Therapy
OTHERGroup-based Acceptance and Commitment Therapy (ACT) for adolescents presenting with multiple functional somatic syndromes.
Interventions
The treatment "ACT for Health in Adolescents" (AHEAD) is an ACT-based Group intervention consisting of 9 modules (27 hours in total) delivered over a period of 3 months, with a follow-up meeting (3 hours) 3 months after the last module. Six to eight patients participate in each treatment Group. An information meeting (3 hours) for close relatives is held at the beginning of the Group treatment and the adolescents and their parents were invited to a 1½-hour individual consultation after the 8th module.
Eligibility Criteria
You may qualify if:
- Bodily Distress Syndrome, multi-organ type of at least 12 months' duration
- Raised since early childhood in Denmark or born by Danish parents
- Understand, speak and read Danish
- Moderate or severe impairment
You may not qualify if:
- Acute psychiatric disorder demanding other treatment, or if the patient is suicidal.
- A lifetime diagnosis of psychosis, mania or depression with psychotic symptoms (ICD-10: F20-29, F30-31, F32.2, F33.3), serious cognitive deficits or developmental disorders such as mental retardation and autism (ICD-10: F70, F84)
- Substance abuse of e.g. narcotics, alcohol or medication.
- Not able to participate in group-based treatment, e.g. patients with severe ADHD (ICD-10: F90), severe social phobia (ICD-10: F40.1) or conduct disorder (ICD-10: F91)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- Aarhus University Hospitalcollaborator
Related Publications (1)
Kallesoe KH, Schroder A, Wicksell RK, Preuss T, Jensen JS, Rask CU. Feasibility of group-based acceptance and commitment therapy for adolescents (AHEAD) with multiple functional somatic syndromes: a pilot study. BMC Psychiatry. 2020 Sep 21;20(1):457. doi: 10.1186/s12888-020-02862-z.
PMID: 32957944DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charlotte U Rask, MD, PhD
Aarhus University and during study the Research Clinic for Functional Disorders and Psychosomatics
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 27, 2020
First Posted
July 9, 2020
Study Start
May 29, 2013
Primary Completion
April 15, 2015
Study Completion
April 24, 2015
Last Updated
June 14, 2021
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share
Has not been incorporated in the consent from the patients. However, some data will be available upon request.